MACKENZIE FINANCIAL CORP - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2023$32,396
+8.7%
28,6690.0%0.00%
Q1 2023$29,816
-20.0%
28,669
-13.8%
0.00%
Q4 2022$37,258
-17.2%
33,266
-15.6%
0.00%
Q3 2022$45,000
-8.2%
39,438
+17.9%
0.00%
Q2 2022$49,000
+81.5%
33,448
+184.5%
0.00%
Q1 2022$27,00011,7570.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders